Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
ganoderma lucidum spore powder granules
- Development stage
- Unknown
- Lead developer
- Hunan Zhongqi Pharmaceutical
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Ganoderma lucidum spore powder granules are a traditional Chinese medicine (TCM) health product derived from the spores of the *Ganoderma lucidum* fungus, commonly known as Lingzhi or Reishi. Developed and marketed by Hunan Zhongqi Pharmaceutical, this product is categorized as a health supplement intended to support immune function and overall health. The spores contain bioactive compounds, primarily polysaccharides and triterpenoids (such as ganoderic acids), which are associated with immunomodulatory, antioxidant, and anti-fatigue properties. The granule formulation is designed for oral administration, often utilizing sporoderm-breaking technology to improve the bioavailability of the internal active components.
- Other names
- Ganoderma lucidum spore powderLingzhi spore powderReishi mushroom spore powder
02
Targets
MAPK3 (Mitogen-activated protein kinase 1)MARK4 (Microtubule affinity-regulating kinase 4)Spike-ACE2 PPI (SARS-CoV-2 spike–ACE2 interface)CYP19A1 (Aromatase)GR (Glucocorticoid receptor)PIK3CA (Phosphoinositide 3-kinase alpha)AKT1 (Proto-oncogene serine/threonine-protein kinase Akt1)CDK2 (Cyclin-dependent kinase 2)mTOR (Mammalian target of rapamycin kinase)TNFA (Tumor necrosis factor alpha (soluble))
Beyond the preview
Go deeper on ganoderma lucidum spore powder granules.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on ganoderma lucidum spore powder granules.